全國(guó)衛(wèi)生產(chǎn)業(yè)企業(yè)管理協(xié)會(huì)實(shí)驗(yàn)醫(yī)學(xué)分會(huì)（PCEM）與Wiley出版集團(tuán)共同主辦的VIEW?（《致瞰（英文）》）獲得首個(gè)影響因子8.6，JCI指數(shù)0.69，在工程技術(shù)各領(lǐng)域表現(xiàn)杰出。期刊創(chuàng)刊于2020年，為雙月刊，主要關(guān)注生命健康的“可視化”，通過(guò)開發(fā)新型材料將“診斷”與“治療”相結(jié)合，創(chuàng)造出更具潛力的新型診斷治療學(xué)技術(shù)實(shí)現(xiàn)精準(zhǔn)醫(yī)療。期刊先后收錄于DOAJ、ESCI、Scopus、CAS、INSPEC等數(shù)據(jù)庫(kù)。2022年度CiteScore為8.6，SNIP指標(biāo)為1.251。

VIEW?is a high-quality, interdisciplinary, and rapid-publication open access journal focusing on “biodiagnostics” in the field of biomaterials. From?in vitro?to?in vivo, small to mega, fundamentals to application, with an emphasis on the biomaterials used particularly in biotechnology and medicine.

Why publish in?VIEW?

• Open access means?your research is available to read, download, and share.
• An opportunity for?transforming research excellence to innovation?with an aspiring premier journal.
• Dedicated?special issues?make your work easily discoverable to like-minded scientists.
• Published in partnership with the?Professional Community of Experimental Medicine. By partnering directly with the community, we've built up the trust to help drive change faster, together.

VIEW?embraces all significant advances in research fields including drug delivery, lab-on-a-chip, microfluidics, bioimaging, biomarkers, omics, biosensors and bioelectronics, computational diagnostics, bioinformatics, and novel diagnostic devices, and more.